On May 27, 2023, the 8th China Experimental Medicine Conference was held successfully at Primus Hotel Nanchang International Expo City.

The conference invited a number of academicians, experts and scholars in the fields of experimental medicine and biomedical engineering to give wonderful presentations and to conduct extensive and in-depth exchanges and discussions on the latest developments in experimental medicine, international cutting-edge technologies and leading scientific research achievements. 

The conference opened with an opening address by Professor Chengbin Wang, Honorary President of the Conference.

Address by Professor Hualiang Wang, Chairman of this year's conference.

The signing ceremony of the framework agreement for strategic cooperation with WILEY, the international publishing company, and the awarding ceremony of the 2022 Innovation Star Cup were held as well.

Mr. Philip Kisray, Senior Vice President of WILEY Publishing Group and General Manager of China, delivered a speech. 

This collaboration mainly focused on jointly launching VIEW journal, a high-quality, interdisciplinary and fast-published journal focusing on "bio-diagnostics" in the field of biomaterials, starting in 2020. 

Through the publication of VIEW Medicine, a sister journal of VIEW, international academic exchanges and dissemination of scientific results will be enhanced, making full use of the strengths of each party in terms of academic resources, scientific research, journal publication and international conferences.

The winners of the 2022 Innovation Star Cup - Outstanding Papers in Laboratory Medicine and Outstanding Innovative Products (Instruments/Reagents) in In Vitro Diagnostics Industry were announced on site.

The winners of Outstanding Paper in Laboratory Medicine are Jiao Wu from Shanghai Jiaotong University, Qinglai Meng from Shanxi University,Yu Song from Shanghai Clinical Laboratory Center and Dazhi Jin from Hangzhou Medical College.

The winners of Outstanding Innovative Products (Instruments) are Joinstar Biomedical Technology Co., Ltd., AVE Science & Technology Co. Ltd., Shanghai Kehua Bio-Engineering Co., Ltd. and Zybio Inc.

The winners of Outstanding Innovative Products (Reagents) are Shandong Kuanghua Biotechnology Co., Ltd., Shenzhen YHLO Biotech Co., Ltd., DaAn Gene Co., Ltd., Zhejiang Disaidi Diagnostic Technology Co., Ltd., Changsha Weimi Bio-Tech Co., Ltd., Dynamiker Biotechnology (Tianjin) Co., Ltd., Hangzhou Proprium Biotech Co., Ltd., Beijing Hotgen Biotech Co., Ltd., Sansure Biotech Co., Ltd., CapitalBio Technology Co., Ltd., Anhui Huibang Biological Engineering Co., Ltd. and New Horizon Health.